Get access

Treatment of intractable epilepsy in tuberous sclerosis complex with everolimus is not yet evidence-based

Authors

  • Iris E. Overwater MSc,

    1. Departments of Neurology, ENCORE Expertise Center for Neurodevelopmental Disorders, Erasmus MC–Sophia Children's Hospital, Rotterdam, the Netherlands
    2. Neuroscience, ENCORE Expertise Center for Neurodevelopmental Disorders, Erasmus MC–Sophia Children's Hospital, Rotterdam, the Netherlands
    Search for more papers by this author
  • André B. Rietman MSc,

    1. Departments of Neurology, ENCORE Expertise Center for Neurodevelopmental Disorders, Erasmus MC–Sophia Children's Hospital, Rotterdam, the Netherlands
    2. Pediatrics, ENCORE Expertise Center for Neurodevelopmental Disorders, Erasmus MC–Sophia Children's Hospital, Rotterdam, the Netherlands
    Search for more papers by this author
  • Ype Elgersma PhD,

    1. Neuroscience, ENCORE Expertise Center for Neurodevelopmental Disorders, Erasmus MC–Sophia Children's Hospital, Rotterdam, the Netherlands
    Search for more papers by this author
  • Marie-Claire Y. de Wit MD, PhD

    1. Departments of Neurology, ENCORE Expertise Center for Neurodevelopmental Disorders, Erasmus MC–Sophia Children's Hospital, Rotterdam, the Netherlands
    Search for more papers by this author

No abstract is available for this article.

Ancillary